Drug
HRS-1893
HRS-1893 is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
20%
Ph phase_1
2
40%
Ph phase_2
2
40%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (20.0%)
Phase 12 (40.0%)
Phase 22 (40.0%)
Trials by Status
recruiting120%
completed360%
active_not_recruiting120%
Recent Activity
2 active trials
Showing 5 of 5
completedearly_phase_1
A Trial of HRS-1893 in Healthy Volunteers
NCT07033455
completedphase_1
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
NCT06775834
active_not_recruitingphase_2
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT06516068
recruitingphase_2
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
NCT06816251
completedphase_1
A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
NCT05879523
Clinical Trials (5)
Showing 5 of 5 trials
NCT07033455Early Phase 1
A Trial of HRS-1893 in Healthy Volunteers
NCT06775834Phase 1
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
NCT06516068Phase 2
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT06816251Phase 2
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
NCT05879523Phase 1
A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5